Clopidogrel and proton pump inhibitors
Copyright policy ) Deepak L. Bhatt;
Clopidogrel and proton pump inhibitors
The points raised by Juurlink[1][1] in response to our article[2][2] are worthy of consideration. The release kinetics of the drugs as given in the COGENT trial may have attenuated the potential for a drug–drug interaction. However, in the absence of any further randomized clinical trial of
- Harvard University United States
Ticlopidine, Humans, Proton Pump Inhibitors, Pantoprazole, 2-Pyridinylmethylsulfinylbenzimidazoles, Omeprazole, Platelet Aggregation Inhibitors, Clopidogrel
Ticlopidine, Humans, Proton Pump Inhibitors, Pantoprazole, 2-Pyridinylmethylsulfinylbenzimidazoles, Omeprazole, Platelet Aggregation Inhibitors, Clopidogrel
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 0
Average
Average
Average
gold
Beta
Related to Research communities